title: Defining non-valvular atrial fibrillation while selecting anticoagulation therapy.
authors: Pankaj
authors: P
authors: Garg
authors: David P
authors: DP
authors: Ripley
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000145:classification / Q000188:drug therapy* / Q000209:etiology; D001562:Benzimidazoles / Q000627:therapeutic use*; D000069604:Dabigatran; D006349:Heart Valve Diseases / Q000150:complications; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use*; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011720:Pyrazoles; D011728:Pyridones; D013876:Thiophenes; D015091:beta-Alanine; C522181:apixaban; D000069552:Rivaroxaban; D000069604:Dabigatran